Single-Cell Analysis Market: Current Analysis and Forecast (2021-2027)

Single-cell analysis is being extensively used by the biopharmaceutical and biotechnology industries to discover new drugs and technologies to treat rare and infectious diseases. For instance, in March 2021, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s supplemental new drug application for “LORBRENA”, expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). LORBRENA is now indicated for adults with metastatic NSCLC whose tumors are ALK-positive as detected by an FDA-approved test. Moreover, the collaborations and partnerships among the key players for developing new products are also boosting the single-cell analysis market. Biogen Inc. and Capsigen Inc. on May 10, 2021, announced their strategic research collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to deliver transformative gene therapies to address the underlying genetic causes of various CNS and neuromuscular disorders.
Moreover, the increasing cases of cancer and other chronic diseases are adding pace to the growth of the single-cell analysis market. According to the Office of Disease Prevention and Health Promotion, more than 25 million people in the United States have asthma. And almost 14.8 million adults are diagnosed with COPD, and nearly 12 million people are not yet been diagnosed with respiratory diseases in 2020. Also, as per the American Cancer Society, in 2020, there were approximately 89,500 cancer cases diagnosed and about 9,270 cancer deaths in adolescents and young adults aged between 15 to 39 years in the US.
The covid-19 pandemic has impacted the single-cell analysis market positively. As the increasing cases of Covid-19 have increased the demand for research to develop a cure for the Covid-19 virus or a vaccine to protect the people from this deadly virus. According to the Wiley Online Library’s report on clinical and translational medicine in May 2021, the scientists were using the combined single-cell and bulk TCR sequencing methods to decode the matching of T cell phenotype and antigenic epitopes for the identification of potential vaccine targets for COVID-19. The growing research in this field to encounter the novel coronavirus will boost the single-cell analysis market in the forecast period.
Thermo Fisher Scientific, Becton, Dickinson and Company, Danaher Corporation, GE Healthcare, Bio-Rad Laboratories, NanoString Technologies, 10x Genomics, Luminex Corporation, Menarini Silicon Biosystems, and QIAGEN are some of the prominent players operating in the single-cell analysis market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Product, Consumable segment holds the major share”
Based on Product, the market is bifurcated into consumables and instruments. The consumable segment grabbed the major market in 2020 due to their frequent consumption and high utility for research purposes. Moreover, the increasing demand for reagents, extensive adoption of beads, and mounting demand for assay kits are also increasing the demand for consumable products in the market.
“Amongst Cell type, Human cell segment is anticipated to grow at the highest CAGR during the analyzed period”
Based on cell type, the market is bifurcated into human cells, animal cells, and microbial cells. The human cells segment grabbed the major market in 2020 and accounted for the maximum market. The largest share of the human cells is accredited due to their major utilization in research laboratories and academic institutes. As the research on chronic and rare diseases is increasing the use of human cells is also increasing and the segment will upsurge over the forecast period.
“Amongst Application, research application segment holds the major share”
Based on application, the market is bifurcated into research applications and medical applications. The research application segment grabbed the major market in 2020 and accounted for the maximum revenue during the forecast period. Increasing government initiatives in Covid-19 research and the wide usage of single-cell analysis in cancer and stem cell research are the major aspects driving the growth of the research applications segment.
“Amongst Technique, Next-Generation Sequencing segment is anticipated to grow at the highest CAGR during the analyzed period”
Based on technique, the market is bifurcated into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. The next-generation sequencing segment is expected to record significant growth over the forecast period owing to their increasing applications in the field of single-cell analysis products for drug discovery of cancer and other chronic diseases across the globe.
“Amongst End-users, Academic & Research Laboratories segment holds the major share”
Based on end-user, the market is bifurcated into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers. The academic & research laboratories segment grabbed the major market in 2020 due to the growing funds for life science research by the government and other private organizations. Moreover, the increasing number of medical colleges and universities are also driving the growth of this academic & research laboratories segment.
“North America signifies one of the largest markets of Single-Cell Anaysis market”
For a better understanding of the market dynamics of the single-cell analysis market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of APAC), Rest of World. North America constitutes a major market for single-cell analysis and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled workforces.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
The Single-Cell Analysis Market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.